Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells.

Brasseur K, Fabi F, Adam P, Parent S, Lessard L, Asselin E.

Oncotarget. 2016 Jun 14;7(24):36971-36987. doi: 10.18632/oncotarget.9235.

2.

Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.

Barnoud T, Wilkey DW, Merchant ML, Clark JA, Donninger H.

Cancers (Basel). 2016 Mar 16;8(3). pii: E37. doi: 10.3390/cancers8030037.

3.

Spatio-Temporal Regulation of PKC Isoforms Imparts Signaling Specificity.

Mukherjee A, Roy S, Saha B, Mukherjee D.

Front Immunol. 2016 Feb 17;7:45. doi: 10.3389/fimmu.2016.00045. eCollection 2016. Review. No abstract available.

4.

The cell biology of aging.

DiLoreto R, Murphy CT.

Mol Biol Cell. 2015 Dec 15;26(25):4524-31. doi: 10.1091/mbc.E14-06-1084. Review.

5.

The activation of the atypical PKC zeta in light-induced retinal degeneration and its involvement in L-DNase II control.

Jaadane I, Chahory S, Leprêtre C, Omri B, Jonet L, Behar-Cohen F, Crisanti P, Torriglia A.

J Cell Mol Med. 2015 Jul;19(7):1646-55. doi: 10.1111/jcmm.12539. Epub 2015 Mar 17.

6.

Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death.

Jagtap JC, Parveen D, Shah RD, Desai A, Bhosale D, Chugh A, Ranade D, Karnik S, Khedkar B, Mathur A, Natesh K, Chandrika G, Shastry P.

FEBS Open Bio. 2014 Nov 21;5:8-19. doi: 10.1016/j.fob.2014.11.005. eCollection 2015.

7.

Cloning, expression, purification, crystallization and preliminary crystallographic analysis of the C-terminal domain of Par-4 (PAWR).

Tiruttani Subhramanyam UK, Kubicek J, Eidhoff UB, Labahn J.

Acta Crystallogr F Struct Biol Commun. 2014 Sep;70(Pt 9):1224-7. doi: 10.1107/S2053230X14014691. Epub 2014 Aug 27.

8.

The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Liu Y, Gilbert MR, Kyprianou N, Rangnekar VM, Horbinski C.

Acta Neuropathol. 2014 Nov;128(5):723-32. doi: 10.1007/s00401-014-1334-7. Epub 2014 Aug 19.

9.

Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis.

Treude F, Kappes F, Fahrenkamp D, Müller-Newen G, Dajas-Bailador F, Krämer OH, Lüscher B, Hartkamp J.

Oncotarget. 2014 May 30;5(10):2988-98.

10.

Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C ζ and ι from typical C1 domains.

Pu Y, Kang JH, Sigano DM, Peach ML, Lewin NE, Marquez VE, Blumberg PM.

J Med Chem. 2014 May 8;57(9):3835-44. doi: 10.1021/jm500165n. Epub 2014 Apr 17.

11.

Expression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-induced apoptosis.

Jagtap JC, Dawood P, Shah RD, Chandrika G, Natesh K, Shiras A, Hegde AS, Ranade D, Shastry P.

PLoS One. 2014 Feb 11;9(2):e88505. doi: 10.1371/journal.pone.0088505. eCollection 2014. Erratum in: PLoS One. 2014;9(4):e95817.

12.

Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.

de Thonel A, Hazoumé A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM, Garrido C.

Cell Death Dis. 2014 Jan 23;5:e1016. doi: 10.1038/cddis.2013.532.

13.

Atypical protein kinase C couples cell sorting with primitive endoderm maturation in the mouse blastocyst.

Saiz N, Grabarek JB, Sabherwal N, Papalopulu N, Plusa B.

Development. 2013 Nov;140(21):4311-22. doi: 10.1242/dev.093922. Epub 2013 Sep 25.

14.

Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.

Alvarez JV, Pan TC, Ruth J, Feng Y, Zhou A, Pant D, Grimley JS, Wandless TJ, Demichele A; I-SPY 1 TRIAL Investigators., Chodosh LA.

Cancer Cell. 2013 Jul 8;24(1):30-44. doi: 10.1016/j.ccr.2013.05.007. Epub 2013 Jun 13.

15.

c-Myc phosphorylation by PKCζ represses prostate tumorigenesis.

Kim JY, Valencia T, Abu-Baker S, Linares J, Lee SJ, Yajima T, Chen J, Eroshkin A, Castilla EA, Brill LM, Medvedovic M, Leitges M, Moscat J, Diaz-Meco MT.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6418-23. doi: 10.1073/pnas.1221799110. Epub 2013 Apr 2.

16.

Functional comparison of protein domains within aPKCs involved in nucleocytoplasmic shuttling.

Seidl S, Braun UB, Leitges M.

Biol Open. 2012 May 15;1(5):436-45. doi: 10.1242/bio.2012505. Epub 2012 Mar 21.

17.

Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators.

Martin P, Moscat J.

Front Immunol. 2012 Aug 6;3:241. doi: 10.3389/fimmu.2012.00241. eCollection 2012.

18.

Mechanisms of apoptosis by the tumor suppressor Par-4.

Hebbar N, Wang C, Rangnekar VM.

J Cell Physiol. 2012 Dec;227(12):3715-21. doi: 10.1002/jcp.24098. Review.

19.

The atypical PKCs in inflammation: NF-κB and beyond.

Diaz-Meco MT, Moscat J.

Immunol Rev. 2012 Mar;246(1):154-67. doi: 10.1111/j.1600-065X.2012.01093.x. Review.

20.

It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.

Bieberich E.

Neurochem Res. 2012 Jun;37(6):1208-29. doi: 10.1007/s11064-011-0698-5. Epub 2012 Jan 14. Review.

Supplemental Content

Support Center